Article Details

Eli Lilly's GLP-1 drug achieves endpoints in Phase 3 sleep apnea trials

Retrieved on: 2024-04-17 22:00:19

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly's GLP-1 drug achieves endpoints in Phase 3 sleep apnea trials. View article details on HISWAI: https://www.mmm-online.com/home/channel/eli-lillys-glp-1-drug-endpoints-phase-3-sleep-apnea-trials/

Excerpt

This treatment led to a mean AHI reduction from baseline of 30.4 events per hour compared to a mean reduction of 6 events per hour for those on the ...

Article found on: www.mmm-online.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up